| Date | Time | Source | Headline | Symbol | Company |
| 05/04/2023 | 4:00PM | GlobeNewswire Inc. | GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 04/26/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Participate in the 4th Symposium on Infectious Diseases in the Immunocompromised Host | NASDAQ:GOVXW | GeoVax Labs Inc |
| 04/25/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Host First Quarter 2023 Business Update and Financial Results Conference Call on May 4, 2023 | NASDAQ:GOVXW | GeoVax Labs Inc |
| 04/06/2023 | 10:00AM | GlobeNewswire Inc. | GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate | NASDAQ:GOVXW | GeoVax Labs Inc |
| 04/05/2023 | 1:30PM | GlobeNewswire Inc. | GeoVax Marburg Vaccine Data Presented at the 23rd Annual World Vaccine Congress | NASDAQ:GOVXW | GeoVax Labs Inc |
| 03/30/2023 | 11:00AM | GlobeNewswire Inc. | GeoVax to Participate at the World Vaccine Congress with Multiple Presentations | NASDAQ:GOVXW | GeoVax Labs Inc |
| 03/23/2023 | 4:00PM | GlobeNewswire Inc. | GeoVax Reports 2022 Year-End Financial Results and Provides Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 03/15/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress | NASDAQ:GOVXW | GeoVax Labs Inc |
| 03/09/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Report 2022 Financial Results on Thursday, March 23, 2023 and Provide Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 03/06/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Participate at the 35th Annual Roth Conference | NASDAQ:GOVXW | GeoVax Labs Inc |
| 02/27/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax Vaccine Data Included in HIV-Therapy Presentation at the Conference on Retroviruses and Opportunistic Infections | NASDAQ:GOVXW | GeoVax Labs Inc |
| 02/15/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial | NASDAQ:GOVXW | GeoVax Labs Inc |
| 02/08/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax Announces Decisive Progress in Establishing High-Capacity, Continuous Cell Line System to Manufacture MVA-based Vaccines | NASDAQ:GOVXW | GeoVax Labs Inc |
| 02/07/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax Expands Gedeptin® Clinical Research for Advanced Head and Neck Cancers | NASDAQ:GOVXW | GeoVax Labs Inc |
| 01/26/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Present at the 2023 BIO CEO & Investor Conference | NASDAQ:GOVXW | GeoVax Labs Inc |
| 01/25/2023 | 11:00AM | GlobeNewswire Inc. | GeoVax Receives Notice of Allowance for Zika Vaccine Patent | NASDAQ:GOVXW | GeoVax Labs Inc |
| 01/04/2023 | 9:00AM | GlobeNewswire Inc. | GeoVax to Present at Biotech Showcase During J.P. Morgan Healthcare Week 2023 | NASDAQ:GOVXW | GeoVax Labs Inc |
| 12/20/2022 | 9:00AM | GlobeNewswire Inc. | Valerie Montgomery Rice, MD, FACOG, President and CEO of Morehouse School of Medicine, Appointed Special Advisor to GeoVax | NASDAQ:GOVXW | GeoVax Labs Inc |
| 12/07/2022 | 4:00PM | GlobeNewswire Inc. | GeoVax Appoints Jayne Morgan, M.D., to its Board of Directors | NASDAQ:GOVXW | GeoVax Labs Inc |
| 11/28/2022 | 10:15AM | GlobeNewswire Inc. | GeoVax to Present at the World Vaccine & Immunotherapy Congress West Coast 2022 | NASDAQ:GOVXW | GeoVax Labs Inc |
| 11/09/2022 | 4:00PM | GlobeNewswire Inc. | GeoVax Reports 2022 Third Quarter Financial Results and Provides Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 10/26/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022 | NASDAQ:GOVXW | GeoVax Labs Inc |
| 10/11/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax to Present at Vaccines Summit-2022 | NASDAQ:GOVXW | GeoVax Labs Inc |
| 09/07/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax to Present at the H.C. Wainwright 24th Annual Global Investment Conference | NASDAQ:GOVXW | GeoVax Labs Inc |
| 09/01/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax Announces Addition to Its Board of Directors | NASDAQ:GOVXW | GeoVax Labs Inc |
| 08/03/2022 | 4:00PM | GlobeNewswire Inc. | GeoVax Reports 2022 Second Quarter Financial Results and Provides Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 07/28/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax Announces Peer-Reviewed Publication in NPJ Vaccines of Preclinical Data for Vaccine Candidate Against Sudan Ebolavirus Showing 100% Protection With a Single Immunization | NASDAQ:GOVXW | GeoVax Labs Inc |
| 07/26/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax to Report Second Quarter 2022 Financial Results on Wednesday, August 3, 2022 and Provide Corporate Update | NASDAQ:GOVXW | GeoVax Labs Inc |
| 06/13/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development | NASDAQ:GOVXW | GeoVax Labs Inc |
| 06/07/2022 | 9:00AM | GlobeNewswire Inc. | GeoVax to Present at BIO International Convention 2022 | NASDAQ:GOVXW | GeoVax Labs Inc |